By Eric Schweibenz
On July 14, 2011, the U.S. International Trade Commission issued a press release announcing that it voted to institute an investigation of Certain Coenzyme Q10 Products and Methods of Making Same (Inv. No. 337-TA-790).

The investigation is based on an June 17, 2011 complaint and June 24 and 27, 2011 supplementary materials filed by Kaneka Corporation of Japan alleging violation of Section 337 in the importation into the U.S. and sale of certain coenzyme Q10 products made by certain processes that infringe one or more claims of U.S. Patent No. 7,910,340.  See our June 21, 2011 post for more details.

According to the Notice of Investigation, the ITC has identified the following entities as the respondents in this investigation:

  • Zhejiang Medicine Co., Ltd. of China

  • ZMC-USA, L.L.C. of The Woodlands, Texas

  • Xiamen Kingdomway Group Co. of China

  • Pacific Rainbow International Inc. of City of Industry, California

  • Mitsubishi Gas Chemical Co., Inc. of Japan

  • Maypro Industries, Inc. of Purchase, New York

  • Shenzhou Biology & Technology Co., Ltd. of China

In addition, Chief ALJ Paul J. Luckern issued a notice indicating that Robert K. Rogers, Jr. will be the presiding Administrative Law Judge in this investigation.